BioPrint meets the AI age: development of artificial intelligence-based ADMET models for the drug-discovery platform SAFIRE.

Saved in:
Bibliographic Details
Title: BioPrint meets the AI age: development of artificial intelligence-based ADMET models for the drug-discovery platform SAFIRE.
Authors: Biehn SE; Eurofins DiscoveryAI, Eurofins Panlabs, Inc., Saint Charles, MO 63304, USA., Goncalves LM; Eurofins DiscoveryAI, Eurofins Panlabs, Inc., Saint Charles, MO 63304, USA., Lehmann J; Eurofins DiscoveryAI, Eurofins Panlabs, Inc., Saint Charles, MO 63304, USA., Marty JD; Eurofins DiscoveryAI, Eurofins Panlabs, Inc., Saint Charles, MO 63304, USA., Mueller C; Eurofins DiscoveryAI, Eurofins Panlabs, Inc., Saint Charles, MO 63304, USA., Ramirez SA; Eurofins DiscoveryAI, Eurofins Panlabs, Inc., Saint Charles, MO 63304, USA., Tillier F; Eurofins DiscoveryAI, Eurofins Panlabs, Inc., Saint Charles, MO 63304, USA., Sage CR; Eurofins DiscoveryAI, Eurofins Panlabs, Inc., Saint Charles, MO 63304, USA.
Source: Future medicinal chemistry [Future Med Chem] 2024 Apr; Vol. 16 (7), pp. 587-599. Date of Electronic Publication: 2024 Feb 19.
Publication Type: Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101511162 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1756-8927 (Electronic) Linking ISSN: 17568919 NLM ISO Abbreviation: Future Med Chem Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1756-8927
DOI:10.4155/fmc-2024-0007